<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of unfavorable prognosis early stage classical Hodgkin lymphoma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of unfavorable prognosis early stage classical Hodgkin lymphoma</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of unfavorable prognosis early stage classical Hodgkin lymphoma</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes our approach to the management of classical Hodgkin lymphoma with: 

<ol>
<li>Early stage 

<ul>
<li>Stage I: Involvement of a single lymph node region or of a single extralymphatic organ or site, or</li>
<li>Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm alone or with involvement of limited contiguous extralymphatic organ or tissue,</li></ul></li>
<li>And at least one of the following unfavorable prognostic features: 

<ol class="numbers_to_nine" style="LIST-STYLE-TYPE: upper-alpha">
<li>Age &gt;50 years,</li>
<li>Large mediastinal adenopathy,</li>
<li>Elevated ESR, or</li>
<li>At least four regions of involvement.*</li></ol></li></ol>Further details are presented in UpToDate content on the treatment of unfavorable prognosis early stage classical Hodgkin lymphoma.</div><div class="graphic_footnotes">ABVD: doxorubicin, bleomycin, vinblastine, and dacarbazine; PET: positron emission tomography; CT: computed tomography; CR: complete response; PR: partial response; PD: progressive disease; ESR: erythrocyte sedimentation rate; cHL: classical Hodgkin lymphoma; BEACOPP: bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone.<br/>* Large mediastinal adenopathy (at least 10 cm or one-third of the cardiothoracic diameter); ESR at least 50 mm/hour with no B symptoms, or ESR at least 30 mm/hour with B symptoms.<br/>¶ For select patients with large mediastinal adenopathy in whom radiation therapy is felt to pose an excessive risk, treatment with six to eight cycles of ABVD is an option; further details are presented in UpToDate content on management of unfavorable prognosis early stage cHL.<br/>Δ The most common initial chemotherapy option is ABVD; some experts suggest alternative regimens (refer to UpToDate content on the treatment of unfavorable prognosis early stage cHL).<br/><font class="lozenge">◊</font> Perform PET/CT just before next scheduled chemotherapy cycle; CR (Deauville 1 to 3), PR (Deauville 4 to 5), PD (radiologic or clinical progression).<br/>§ Some experts recommend changing to BEACOPP if PR after two cycles of ABVD; further details are presented in UpToDate content on management of unfavorable prognosis early stage cHL.<br/>¥ Total of six cycles of ABVD is preferred for patients with unfavorable prognosis cHL.<br/>‡ If PR after ABVD cycle 4, a decision to proceed with two additional cycles of ABVD versus salvage systemic chemotherapy depends on the clinician's judgment regarding chemotherapy responsiveness of cHL.<br/>† Further details are presented in UpToDate content on the treatment of relapsed or refractory cHL.<br/>** Routine PET/CT surveillance is not recommended after achievement of CR; further details are presented in UpToDate content on monitoring the patient with cHL during and after treatment.</div><div id="graphicVersion">Graphic 114572 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
